Lupin P/B Ratio
Lupin (LUPIN) P/B ratio is 5.12 (High), book value per share ₹2473.96 vs Healthcare average P/B of -0.31 — Very High - Significant premium, high growth expectations or speculative. For live price, earnings yield and the full fundamental profile, see Lupin stock price NSE.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
LUPIN P/B Ratio — Valuation Insights & Book Value Analysis
Lupin price-to-book ratio interpretation, valuation status and historical context — current P/B 5.12 (High). Review LUPIN P/E ratio to evaluate earnings-based valuation against sector peers.
- Stock appears overvalued with PB of 5.12, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 404.9% above historical average
- Trading at premium to sector average PB of -0.31
Lupin P/B Ratio Historical Trend
LUPIN annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. View LUPIN 52-week chart for the annual high/low range and current price position.
LUPIN Historical P/B Ratio — Book Value Per Share & Year-End Price
Lupin annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 0.96 | ₹2473.96 | ₹2370.50 | ₹22,513 | Low |
| 2025 | 1.11 | ₹1900.44 | ₹2109.50 | ₹17,294 | Moderate |
| 2024 | 1.49 | ₹1579.56 | ₹2355.70 | ₹14,374 | Moderate |
| 2023 | 0.96 | ₹1378.35 | ₹1322.95 | ₹12,543 | Low |
| 2022 | 0.55 | ₹1343.08 | ₹733.70 | ₹12,222 | Low |
LUPIN vs Healthcare Peers — P/B Ratio Comparison
Lupin P/B 5.12 vs Healthcare average -0.31, median 0.57 — range -14.47–1.1.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -14.47 | ₹18 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Parmax Pharma | PARMAX | -5.61 | ₹39 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.22 | ₹72 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.71 | ₹115 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.5 | ₹44 | Low |